[go: up one dir, main page]

DK2704705T3 - Anvendelse af bethanechol til behandling af xerostomi - Google Patents

Anvendelse af bethanechol til behandling af xerostomi Download PDF

Info

Publication number
DK2704705T3
DK2704705T3 DK12720944.3T DK12720944T DK2704705T3 DK 2704705 T3 DK2704705 T3 DK 2704705T3 DK 12720944 T DK12720944 T DK 12720944T DK 2704705 T3 DK2704705 T3 DK 2704705T3
Authority
DK
Denmark
Prior art keywords
xerostomy
bethanechol
treatment
Prior art date
Application number
DK12720944.3T
Other languages
English (en)
Inventor
Ian Walker
Michael Frodsham
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Application granted granted Critical
Publication of DK2704705T3 publication Critical patent/DK2704705T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK12720944.3T 2011-05-06 2012-05-04 Anvendelse af bethanechol til behandling af xerostomi DK2704705T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1107533.0A GB201107533D0 (en) 2011-05-06 2011-05-06 Formulaiton
PCT/GB2012/050976 WO2012153110A1 (en) 2011-05-06 2012-05-04 Use of bethanechol for treatment of xerostomia

Publications (1)

Publication Number Publication Date
DK2704705T3 true DK2704705T3 (da) 2016-03-21

Family

ID=44243678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12720944.3T DK2704705T3 (da) 2011-05-06 2012-05-04 Anvendelse af bethanechol til behandling af xerostomi

Country Status (6)

Country Link
US (1) US9492546B2 (da)
EP (1) EP2704705B1 (da)
DK (1) DK2704705T3 (da)
ES (1) ES2565653T3 (da)
GB (1) GB201107533D0 (da)
WO (1) WO2012153110A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3164386A1 (en) 2020-02-18 2021-08-26 Kana Hashimoto Oral care composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683783B2 (ja) 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
US5766620A (en) 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
ZA9610154B (en) 1995-12-12 1997-06-17 Universiteit Van Preporia Mouthwash
GB9618341D0 (en) * 1996-09-03 1996-10-16 Scotia Holdings Plc Method of treatment
CN1127333C (zh) 1997-02-24 2003-11-12 S.L.A.药业股份公司 含有胆碱能药物或钙通道阻滞剂的局部用医药组合物
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20070190090A1 (en) 2006-02-07 2007-08-16 Whitehill Oral Technologies, Inc. Sialagogue based oral care products
CA2677281C (en) 2007-02-09 2019-10-29 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
SI2498771T1 (sl) 2009-11-12 2014-04-30 Acacia Pharma Limited Uporaba betanekola za zdravljenje kserostomije

Also Published As

Publication number Publication date
US9492546B2 (en) 2016-11-15
EP2704705A1 (en) 2014-03-12
WO2012153110A1 (en) 2012-11-15
ES2565653T3 (es) 2016-04-06
EP2704705B1 (en) 2015-12-30
US20140187629A1 (en) 2014-07-03
GB201107533D0 (en) 2011-06-22

Similar Documents

Publication Publication Date Title
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2684610T4 (da) Bruser
BR112014002399A2 (pt) conjunto
EP2692380A4 (en) SYRINGE
DK2785349T4 (da) Kombinationsbehandling af cancer
BR112014012016A2 (pt) compostos
BR112014013850A2 (pt) conjunto de prateleiras
DK2785801T4 (da) Fremgangsmåde til formindskelse af isdannelse på et underlag
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2782565T3 (da) Anvendelse af aryl- og hetarylcarboxamider som endoparasiticider
DK2692448T3 (da) Brusehoved
DK3581199T3 (da) Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis
DK2906219T3 (da) Orvepitant til behandling af kronisk pruritus
EP2663189A4 (en) Combination
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
DK3202769T3 (da) Fremgangsmåde til oprensning af phosphaplatinforbindelser
DK2705847T3 (da) Sammensætning til behandling af psoriasis
DK2920151T3 (da) Fremgangsmåde til fremstilling af carboxamider
BR302013000068S1 (pt) Configuração aplicada em bacia
DK3536410T3 (da) Fremgangsmåde til behandling af affaldsgenstande
DK2888228T3 (da) Inhibitorer af CD40-TRAF6 interaktion
DK2838850T3 (da) Oprensning af titantetrachlorid
DK3919060T3 (da) Ecopipam til behandling af Tourettes syndrom